U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Tuesday.Henry Schein reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.30 per share. The company reported quarterly sales of $3.437 billion which beat the analyst consensus estimate of $3.345 billion.Henry Schein shares jumped 8.3% to $87.24 on Tuesday.Here are some other big stocks recording gains in today’s session.Photo via Shutterstock ...

Core Viewpoint - AXT (AXTI) reported Q4-2025 financial results that were in line with expectations, despite a revenue decrease attributed to delayed export permits. The company anticipates a stronger Q1-2026 as it resumes fulfilling its backlog for indium phosphide, leading to a rally in its stock price [1]. Financial Performance - Revenue for Q4-2025 decreased due to delays in export permits [1]. - The company expects Q1-2026 to show improvement as it addresses its backlog for indium phosphide [1]. - The stock price of AXT experienced a rally following the financial results announcement [1].

U.S. stocks settled higher on Friday, with the Dow Jones index gaining more than 200 points during the session after the Supreme Court struck down President Donald Trump’s tariffs.Major indices also recorded gains last week, with the Dow adding 0.3% and the S&P 500 gaining 1.1%. The tech-heavy Nasdaq also jumped 1.5% last week.Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Ev ...

分组1 - AXT reported a quarterly loss of $0.05 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.04, representing an earnings surprise of -15.47% [1] - The company posted revenues of $23.04 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 10.14%, compared to year-ago revenues of $25.1 million [2] - AXT shares have increased by approximately 44% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] 分组2 - The earnings outlook for AXT is uncertain, with current consensus EPS estimates of -$0.04 on $26.69 million in revenues for the coming quarter and -$0.01 on $122.53 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Electronics - Semiconductors is currently in the top 35% of over 250 Zacks industries, indicating a favorable industry outlook [8] - AXT has a Zacks Rank of 4 (Sell), suggesting that the stock is expected to underperform the market in the near future due to unfavorable estimate revisions [6]

AXT (NasdaqGS:AXTI) Q4 2025 Earnings call February 19, 2026 04:30 PM ET Company ParticipantsGary Fischer - CFOLeslie Green - Investor RelationsMorris Young - CEOTim Bettles - VP of Business DevelopmentConference Call ParticipantsMatt Bryson - AnalystRichard Shannon - AnalystTim Savageaux - AnalystOperatorGood afternoon, everyone, and welcome to AXT's fourth quarter 2025 financial conference call. Leading the call today is Dr. Morris Young, Chief Executive Officer, and Gary Fischer, Chief Financial Officer. ...

AXT (NasdaqGS:AXTI) Q4 2025 Earnings call February 19, 2026 04:30 PM ET Company ParticipantsGary Fischer - CFOLeslie Green - Investor RelationsMorris Young - CEOTim Bettles - VP of Business DevelopmentConference Call ParticipantsMatt Bryson - AnalystRichard Shannon - AnalystTim Savageaux - AnalystOperatorGood afternoon, everyone, and welcome to AXT's Q4 2025 financial conference call. Leading the call today is Dr. Morris Young, Chief Executive Officer, and Gary Fischer, Chief Financial Officer. In addition, ...

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $23.0 million, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024 [4] - Non-GAAP gross margin in Q4 was 21.5%, compared to 22.6% in Q3 2025 and 18.0% in Q4 2024 [5] - Non-GAAP operating loss in Q4 2025 was $2.6 million, an increase from a loss of $384,000 in Q3 2025 and a loss of $5.4 million in Q4 2024 [6][7] - Cash and investments increased by $97.2 million to $128.4 million as of December 31, primarily due to a public offering [9] Business Line Data and Key Metrics Changes - Revenue from Indium Phosphide was $8.0 million, primarily from data center applications, while Gallium Arsenide generated $7.0 million [4] - Revenue from consolidated raw material joint ventures was $7.6 million in Q4 [4] - The backlog for indium phosphide wafers reached over $60 million, indicating strong demand [16] Market Data and Key Metrics Changes - Revenue from Asia Pacific accounted for 81.5% of total revenue, Europe 17.5%, and North America 1% [4] - Revenue related to the data center market in China is expected to grow by more than 60% in Q1 2026 compared to Q4 2025 [18] Company Strategy and Development Direction - The company plans to list its subsidiary, Tongmei, on the STAR Market in Shanghai, focusing on the growing demand for indium phosphide substrates in AI infrastructure [10] - AXT is expanding its capacity, aiming to double it by the end of 2026, with a focus on six-inch indium phosphide products [19][53] - The company is actively engaging with customers to understand their long-term requirements and align expansion plans globally [19] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment over the number of export permits received in Q4 but noted improvements in Q1 [14] - The company expects sequential revenue growth in Q1, driven by indium phosphide demand for AI data centers [15] - The geopolitical environment is affecting the export permit process, which remains a significant gating factor for growth [23] Other Important Information - The company is focused on improving gross margins, controlling operating expenses, and reducing inventory [24] - The management highlighted the importance of maintaining efficiency in operations to meet growing demand [23] Q&A Session Summary Question: Revenue number for the quarter - The company confirmed a revenue number of approximately $26 million for Q1, with potential upside if more permits are received [31][32] Question: Licensing process insights - The licensing process has become less predictable, with some permits being denied but with instructions for resubmission [40][41] Question: Backlog and customer ordering patterns - Customers are placing longer-term orders, with forecasts extending beyond 2030, indicating strong demand [50] Question: Capacity additions and CapEx requirements - The company plans to double its capacity by the end of 2026, requiring approximately $30 million for the initial phase [53] Question: Demand and shipment capabilities - If permits were not a constraint, the company could potentially ship $20 million worth of indium phosphide, with expectations to increase to $35 million by year-end [90][91]

Group 1 - U.S. stocks exhibited mixed performance, with the Nasdaq increasing by approximately 100 points on Monday [1] - Valaris shareholders will receive 15.235 shares of Transocean stock for each Valaris share in an all-stock transaction [1] - Valaris shares surged by 21.8%, reaching a price of $76.02 on Monday [1]

Company Overview - AXT, Inc. specializes in the development and production of advanced semiconductor substrates for high-growth applications in communications, photonics, and energy [5] - The company generates revenue by designing, manufacturing, and distributing high-purity semiconductor substrates and related materials using proprietary vertical gradient freeze technology [8] - AXT serves technology manufacturers and OEMs across various regions including the United States, China, Europe, Japan, Taiwan, and Korea, targeting sectors such as telecommunications, data centers, consumer electronics, and industrial applications [8] Financial Metrics - As of February 2, 2026, AXT's share price was $20.94, reflecting a 911.6% increase over the past year, significantly outperforming the S&P 500 by 886.42 percentage points [2] - The company's market capitalization is $1.15 billion, with a trailing twelve months (TTM) revenue of $90.39 million and a TTM net income of -$22.98 million [3] Recent Developments - Maytree Asset Management Ltd reported a new holding of 682,299 shares in AXT during the fourth quarter, with an estimated transaction value of $11.16 million [1] - This new position in AXT represents 8.27% of Maytree's 13F reportable assets, making AXT one of the firm's top five holdings [2][9] - The transaction indicates a bullish outlook towards AXT, which has seen its shares rise from a 52-week low of $1.13 to a high of $26.66, driven by the booming artificial intelligence market [10]

Company Overview - AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates, with a market cap growth from $300 million to $1.3 billion over the past six months, reflecting a nearly 1,000% increase [3] - The company's share was trading at $18.54 as of January 30th, with a forward P/E of 24.21 [1][3] Market Dynamics - The shift from traditional copper cabling to optical communications, driven by the demand for bandwidth from the AI boom, positions AXT as a critical supplier for high-performance data centers [4][3] - AXT is a leading manufacturer of Indium Phosphide (InP) substrate wafers, essential for producing reliable photonic lasers [4] Financial Performance - AXT benefits from a pricing arbitrage, sourcing raw materials at $415/kg from China compared to $800/kg for Western competitors, leading to a significant margin advantage [5] - The company is projected to achieve 32% revenue growth and 223% EBITDA growth in FY26, although it currently has negative net income margins at -18% [5] Strategic Positioning - AXT operates in a duopoly with Sumitomo Electric Industries, reinforcing its strategic importance in the optics supply chain [5] - The market values AXT at 11.6x NTM sales and 182x NTM EBITDA, indicating a growth narrative driven by strategic importance rather than traditional valuation metrics [6] Geopolitical Considerations - The company faces geopolitical risks due to its U.S. headquarters and China-based manufacturing, which could disrupt cash flows and revenue through export license delays or trade restrictions [6]